AI and Cancer Research ── Cancer biology ── 2026-10-28
Cancer molecular biology and AI
- Abstract
Light-activated drugs are a promising way to treat localized diseases for which existing treatments have severe side effects. However, their development is complicated by the set of photophysical and biological properties that must be simultaneously optimized. Here we used computational techniques to find a set of promising candidates for the photoactive inhibition of the poly(ADP-ribose) polymerase 1 (PARP1) cancer target. Using our recently developed methods based on atomistic simulation and machine learning (ML), we screened a set of 5 million hypothetical photoactive ligands. Our workflow used protein-ligand docking to identify candidates with differential PARP1 binding under light and dark conditions; ML force fields and quantum chemistry calculations to predict pKa, absorption spectra, and thermal half-lives; graph-based surrogate models to screen additional compounds; excited-state nonadiabatic dynamics with ML force fields to estimate quantum yields; and free energy perturbation (FEP) to refine binding predictions. From these predictions, we prioritized a small set of synthetically feasible candidates expected to have red-shifted absorption spectra, thermal half-lives on the order of seconds to minutes, and isomer-dependent PARP1 binding under visible-light control. We synthesized 10 candidates and experimentally characterized their photobehavior and PARP1 inhibition constants. Among the validated compounds, 1 showed a 15-fold increase in inhibition of PARP1 upon green-light irradiation at 519 nm (208.8 ± 28.3 μM vs 14.4 ± 1.9 μM). These results validate the computation-guided screening strategy for identifying red-shifted PARP1 photoinhibitors, while also underscoring current limitations such as rapid thermal relaxation in aqueous media.
Journal IF-equivalent: 17.8 (OpenAlex 2-year mean citedness, value as of 2026-10-26, retrieved 2026-10-28; not the official Clarivate IF)Reference: Axelrod S, Kašpar M, Jelínková K, Šmídková M, Bartůňková E, Štěpánová S, et al. Computational Design and Experimental Validation of Photoactive PARP1 Inhibitors. Journal of the American Chemical Society. 2026 Sep 14;148(37):39657-69. doi:10.1021/jacs.6c08644.Checked: Abstract only